Amid the all-time high stocks in today’s market is Incyte Corporation (NASDAQ:INCY) that had a market cap of 27.71 B. The company’s P/E was valued at *TBA as it measures its current share price to its per-share earnings. At present, …
Incyte Corporation
Incyte Corporation (NASDAQ:INCY) stock was up on Thursday on promising results for one of its lung cancer drugs. Incyte Corporation’s lung cancer drug that saw …
Incyte Corporation
The firm owned 15,035 shares of the biopharmaceutical company’s stock after …
BNS3d
Investment
O: Ian Happ is one I am watching, even though he is a rookie. J: Actually, I was hoping that you would discuss a stock. O: Oh. I can discuss one of my specific …
Health care
XAutoplay: On | Off Incyte (INCY) stock popped to a month-high Thursday after its immuno-oncology drug proved effective in matchups with Merck's (MRK) …
Merck
Incyte, a $25 billion biotech company, revealed some new data about its cancer drugs on Wednesday, and the stock popped. The drugmaker, which has one …
promising cancer data
The stock's May 157.50 call was most active on Monday, and it looks like new positions were purchased. In other words, the call buyers expect AAPL to rally …
Sangamo Therapeutics
While we are positive on the company's efforts to expand Jakafi's label, any development/regulatory setback could pull down the stock significantly. In Feb 2016, Incyte received a notice letter regarding an abbreviated new drug application …
Announces Positive Data
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial …